Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders

NCT02663648 is registered in ClinicalTrials.gov with Shandong University as lead sponsor.

NCT NCT02663648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02663648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders
Lead sponsor
Shandong University
Phase
Observational
Overall status
Withdrawn
Start date
June 30, 2016
Completion date
June 30, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia, essential thrombocythemia, myelofibrosis, myeloproliferative disorders, polycythemia vera